Back to search

National and Kapodistrian University of Athens

Η επίδραση πολυμορφισμών των β2-αδρενεργικών υποδοχέων σε ασθενείς με ισχαιμική καρδιοπάθεια στον ελληνικό πληθυσμό

Abstract

dc:description

Introduction: Heart failure (HF) is widely recognised as a progressive process, which is adrenergically activated and involves several physiopathological mechanisms and genetic polymorphisms. An increase in cardiac sympathetic drive is one of the earliest neurohormonal responses occurring in patients with heart failure, and may be one of the major causes of progressive remodeling leading to the decline in myocardial function and the poor prognosis of patients with heart failure. The mainstay of our current medical therapy is the use of different neurohormonal antagonists including b-blockers. The beneficial effects of b-blockers in HF have been clearly demonstrated in different clinical trials, and result from a number of alterations in the activation and deactivation of adrenergic receptor pathways. Previous studies suggest that polymorphisms of the adrenergic receptors might alter the risk for heart failure and the response to treatment with b-blockers. However, the complex haplotypes resulting from combinations of individual polymorphisms have not yet been investigated, and firm conclusions or recommendations for patient management cannot be made because of the low patient numbers in each of the study groups. In our study, we examined the frequency and impact of the polymorphisms of b2 adrenergic receptors Gln27Glu, Arg16Gly and Arg19Cys to the Greek population of patients with ischaemic heart failure. Methods: The study population consisted of 136 controls and 155 heart failure patients, who were symptomatic in NYHA class II-IV, stable coronary artery disease confirmed by angiography or history of myocardial infarction and recent echocardiography with left ventricular systolic function estimated ≤35%. Consent and venous blood samples were obtained from all patients during admission to the protocol, followed by DNA isolation and PCR with either sequencing (48 HF patients and 52 controls) or restriction enzyme digestion (107 HF patients and 84 controls) to analyse genotyping. Results: The results suggest that there was no difference in the allele distribution between controls and HF patients for Gln27Glu and for Arg16Gly. However, there was a difference between the two groups in terms of the distribution for Arg19Cys. The Arg19Cys category was most common for controls, but following analysis of the alleles Arg/Cys in the groups this significant difference was not confirmed (P-value=0.445). The results suggested no strong evidence that any of the patient characteristics varied between the three categories regarding Gln27Glu polymorphism but there was evidence of significant difference in the occurrence of a previous MI which was higher in the Gln27Gln patients (P-value=0.02) vs Gln27Glu / Glu27Glu. The results also suggested there was no statistically significant difference between the three Arg16Gly categories for the majority of the patient characteristics, but significant difference was observed in the proportion of diabetes which was lower in the Gly16Gly patients (P=0.01). A final set of analyses compared the differences in patient characteristics between the three different Arg19Cys categories. Difference between categories was observed for the occurrence of a previous MI (P=0.009), and also in terms of the use of betablockers (P=0.008). The small number of patients investigated for polymorphisms Arg16Gly and Arg19Cys and overall the fact that there was no follow-up of the patients, highlight certain limitations in terms of safe conclusions. Conclusions: In the present study we examined the frequency and impact of different polymorphisms of b2 adrenergic receptors in a Greek population of heart failure patients with severely impaired left ventricular systolic function. We have demonstrated that there is no statistically significant difference in the frequency of polymorphisms between HF patients and controls, but patients with Gln27Glu / Glu27Glu and carriers of allele Cys (Arg19Cys or Cys19Cys) had reduced incidence of myocardial infarction. It was also found that Gly16Gly patients had significantly reduced incidence of diabetes mellitus. However the exact mechanisms by which polymorphisms of beta adrenergic receptors exert their biological effects in ischaemic heart failure are still not clear and further studies are required to evaluate the contribution of polymorphisms in the pathophysiology of heart failure.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2017

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Metaxa, Sofia
  • Μεταξά, Σοφία

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/42316

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Metaxa, Sofia; Μεταξά, Σοφία. Η επίδραση πολυμορφισμών των β2-αδρενεργικών υποδοχέων σε ασθενείς με ισχαιμική καρδιοπάθεια στον ελληνικό πληθυσμό. National and Kapodistrian University of Athens, 2017. http://hdl.handle.net/10442/hedi/42316